QI
KIN

QS Investors’s Kindred Biosciences, Inc. KIN Stock Holding History

QS Investors’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$699K Hold
76,200
– – 0.01% 607
2021
Q1 		$379K Buy
+76,200
New +$368K ﹤0.01% 898

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

QS Investors's KIN Position: Q2 2021 in Review

QS Investors held its Kindred Biosciences, Inc. (KIN) position steady in Q2 2021 at 76,200 shares worth $699K. The position accounts for 0.01% of the portfolio, ranked #607.

QS Investors first reported a position in KIN in Q1 2021 and has held it in 2 quarters since. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • QS Investors held 76,200 shares of Kindred Biosciences, Inc. worth $699K as of Q2 2021.
  • QS Investors left its Kindred Biosciences, Inc. share count unchanged in Q2 2021.
  • Kindred Biosciences, Inc. made up 0.01% of QS Investors's portfolio in Q2 2021, its #607 holding.
  • QS Investors first reported a position in Kindred Biosciences, Inc. in Q1 2021 and has held it in 2 quarters since.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.